Search > Results
You searched for: EV210383 (EV-TRACK ID)
Showing 1 - 2 of 2
Showing 1 - 2 of 2
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV210383 | 1/2 | Mus musculus | Serum | ExoQuick | Mkrtchian, Soiuren | 2022 | 75% | |
Study summaryFull title
All authors
Souren Mkrtchian, Anette Ebberyd, Rosanne E. Veerman, María Méndez-Lago, Susanne Gabrielsson, Lars I. Eriksson, and Marta Gómez-Galán
Journal
Front Immunol
Abstract
Surgical interventions rapidly trigger a cascade of molecular, cellular, and neural signaling respon (show more...)
EV-METRIC
75% (98th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Serum
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
ExoQuick
Protein markers
EV: CD63/ CD81/ HSP70
non-EV: Albumin/ Argonaute?2/ Calreticulin/ GM130/ PMP70/ Prohibitin/ Tamm-Horsfall protein Proteomics
yes
Show all info
Study aim
Identification of content (omics approaches)
Sample
Species
Mus musculus
Sample Type
Serum
Separation Method
Commercial kit
ExoQuick
Other
Name other separation method
ExoQuick
Characterization: Protein analysis
Protein Concentration Method
microBCA
Protein Yield (µg)
0.75
Western Blot
Detected EV-associated proteins
CD63/ CD81/ HSP70
Not detected contaminants
Albumin
Proteomics database
Yes
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Modus
Reported size (nm)
100
EM
EM-type
Transmission-EM
Image type
Close-up, Wide-field
|
||||||||
EV210383 | 2/2 | Mus musculus | Serum | IAF | Mkrtchian, Soiuren | 2022 | 75% | |
Study summaryFull title
All authors
Souren Mkrtchian, Anette Ebberyd, Rosanne E. Veerman, María Méndez-Lago, Susanne Gabrielsson, Lars I. Eriksson, and Marta Gómez-Galán
Journal
Front Immunol
Abstract
Surgical interventions rapidly trigger a cascade of molecular, cellular, and neural signaling respon (show more...)
EV-METRIC
75% (98th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Serum
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Immunoaffinity capture (non-commercial)
Protein markers
EV: CD63/ CD81/ HSP70
non-EV: Albumin/ Argonaute?2/ Calreticulin/ GM130/ PMP70/ Prohibitin/ Tamm-Horsfall protein Proteomics
yes
Show all info
Study aim
Identification of content (omics approaches)
Sample
Species
Mus musculus
Sample Type
Serum
Separation Method
Immunoaffinity capture
Selected surface protein(s)
CD9/ CD63/ CD81
Characterization: Protein analysis
Protein Concentration Method
microBCA
Protein Yield (µg)
0.75
Western Blot
Detected EV-associated proteins
CD63/ CD81/ HSP70
Detected contaminants
Albumin
Proteomics database
Yes
Characterization: RNA analysis
RNA analysis
Type
(RT)?(q)PCR/ RNA?sequencing
Database
NGI
Proteinase treatment
No
RNAse treatment
No
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Modus
Reported size (nm)
100
EM
EM-type
Transmission-EM
Image type
Close-up, Wide-field
|
||||||||
1 - 2 of 2 |
EV-TRACK ID | EV210383 | |
---|---|---|
species | Mus musculus | |
sample type | Serum | |
condition | Control condition | |
separation protocol | ExoQuick | IAF capture (non-commercial) |
Exp. nr. | 1 | 2 |
EV-METRIC % | 75 | 75 |